DEBORAH PEARCE: Open Payments
NPI 1497983662 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$488 in 6 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $517 · 2025 $488
Food & beverage: $488
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $201 |
| Neurocrine BioSciences, Inc. | 2 | $105 |
| Novo Nordisk Inc | 1 | $96 |
| Janssen Pharmaceuticals, Inc | 1 | $86 |
Products named: INGREZZA, UZEDY, AUSTEDO XR, Ozempic, INVEGA SUSTENNA.
Industry payments across MD — which companies pay providers there.
